Skip to main content
Molecular Partners AG (SWX:MOLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
3.230
+0.005 (0.16%)
Apr 4, 2025, 10:36 AM CET

Molecular Partners AG Revenue

In the year 2024, Molecular Partners AG had annual revenue of 4.97M CHF, down -29.38%.

Revenue
4.97M
Revenue Growth
-29.38%
P/S Ratio
22.08
Revenue / Employee
31.26K
Employees
159
Market Cap
118.92M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20244.97M-2.07M-29.38%
Dec 31, 20237.04M-182.56M-96.29%
Dec 31, 2022189.60M179.85M1,843.82%
Dec 31, 20219.75M410.00K4.39%
Dec 31, 20209.34M-11.04M-54.16%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Roche Holding AG 62.40B
Novartis AG 46.87B
Alcon 8.98B
Lonza Group AG 6.57B
Galderma Group AG 4.02B
Straumann Holding AG 2.50B
Sandoz Group AG 9.41B
Sonova Holding AG 3.71B
Revenue Rankings

Molecular Partners AG News

More News